omeprazole has been researched along with Atrophy, Muscle in 1 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Omeprazole ameliorates cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90." | 8.12 | Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole. ( Gao, S; Li, M; Li, YP; Liu, Z; Sun, K; Xiong, J; Zhang, G; Zhu, MX, 2022) |
| "Omeprazole ameliorates cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90." | 4.12 | Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole. ( Gao, S; Li, M; Li, YP; Liu, Z; Sun, K; Xiong, J; Zhang, G; Zhu, MX, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Z | 1 |
| Xiong, J | 1 |
| Gao, S | 1 |
| Zhu, MX | 1 |
| Sun, K | 1 |
| Li, M | 1 |
| Zhang, G | 1 |
| Li, YP | 1 |
1 other study available for omeprazole and Atrophy, Muscle
| Article | Year |
|---|---|
Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole.
Topics: Animals; Cachexia; Carcinoma, Lewis Lung; Mice; Muscle Fibers, Skeletal; Muscular Atrophy; Omeprazol | 2022 |